PureTech Health CEO Bharatt Chowrira steps down
Clinical-stage biotherapeutics company PureTech Health Plc said on Wednesday that chief executive officer Bharatt Chowrira has stepped down with immediate effect.
The board of directors has appointed Robert Lyne as interim CEO with immediate effect.
Lyne joined PureTech as chief portfolio officer in January 2024 and is an experienced leader of UK-listed life science innovation and venture capital companies, having previously served as CEO of Arix Bioscience.
PuretTech said he will continue to work closely with the board and management team as the company "delivers on its strategic objectives".
Interim chair Sharon Barber-Lui said: "The board is grateful to Bharatt for his leadership and dedication to the company over the past eight years. On behalf of the board, I would like to sincerely thank him for his many contributions and wish him every success in the future.
"We remain focused on driving shareholder value, and Rob's extensive operational and capital markets experience will be key as he collaborates with the Board and engages with shareholders."
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
